Israeli start-up Zebra Medical Vision is set to expand its footprint in the US after gaining its first 510(k) clearance from the Food and Drug Administration. The company's algorithms have already received 30 from the European Union, while the 510(k) approval is for its Coronary Calcium Scoring algorithm, which can potentially speed up diagnosis of cardiovascular disease. In June, Zebra raised $seven CE marksm in a series C funding round, featuring Johnson & Johnson Innovation JJDC, among others.
Israeli start-up Zebra Medical Vision is set to expand its footprint in the US after gaining its first 510(k) clearance from the Food and Drug Administration. The company's algorithms have already received seven CE marks from the European Union, while the 510(k) approval is for its Coronary Calcium Scoring algorithm, which can potentially speed up diagnosis of cardiovascular disease. In June, Zebra raised $30m in a series C funding round, featuring Johnson & Johnson Innovation JJDC, among others.